Stefán Jökull Sveinsson
No más puestos en curso
Perfil
Stefán Jökull Sveinsson currently works at Nepsone ehf, as Chief Executive Officer and Akthelia ehf, as Director.
Mr. Sveinsson also formerly worked at Actavis Group hf, as Chief Executive Officer-Research & Development from 2002 to 2010, Oculis SA, as Director, the University of Iceland, as Professor from 1991 to 1993, and Actavis, Inc., as Executive Vice President-Research & Development from 2002 to 2013.
Mr. Sveinsson received his graduate degree from Dalhousie University.
Cargos activos de Stefán Jökull Sveinsson
Empresas | Cargo | Inicio |
---|---|---|
Akthelia ehf
Akthelia ehf Pharmaceuticals: MajorHealth Technology Akthelia ehf manufactures pharmaceutical products. It focuses on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The company was founded by Eirikur Steingrimsson and Eirikur Steingrímsson and is headquartered in Reykjavik, Iceland. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Stefán Jökull Sveinsson.
Empresas | Cargo | Fin |
---|---|---|
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Director/Miembro de la Junta | 04/01/2019 |
Actavis, Inc. /Old/
Actavis, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Actavis, Inc. is engaged in developing, manufacturing and sale of generic pharmaceuticals. They provide a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. The company is located in Morristown, NJ. | Director Técnico/Científico/I+D | 24/01/2013 |
University of Iceland | Corporate Officer/Principal | 01/01/1993 |
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Director Técnico/Científico/I+D | - |
Formación de Stefán Jökull Sveinsson.
Dalhousie University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
Actavis, Inc. /Old/
Actavis, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Actavis, Inc. is engaged in developing, manufacturing and sale of generic pharmaceuticals. They provide a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. The company is located in Morristown, NJ. | Health Technology |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Commercial Services |
Akthelia ehf
Akthelia ehf Pharmaceuticals: MajorHealth Technology Akthelia ehf manufactures pharmaceutical products. It focuses on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The company was founded by Eirikur Steingrimsson and Eirikur Steingrímsson and is headquartered in Reykjavik, Iceland. | Health Technology |
- Bolsa de valores
- Insiders
- Stefán Jökull Sveinsson